Boston Partners’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-27,572
| Closed | -$904K | – | 775 |
|
|
2022
Q2 | $904K | Sell |
27,572
-7,915
| -22% | -$250K | ﹤0.01% | 526 |
|
|
2022
Q1 | $933K | Buy |
35,487
+630
| +2% | +$15.4K | ﹤0.01% | 550 |
|
|
2021
Q4 | $827K | Hold |
34,857
| – | – | ﹤0.01% | 557 |
|
|
2021
Q3 | $874K | Sell |
34,857
-4,186
| -11% | -$107K | ﹤0.01% | 537 |
|
|
2021
Q2 | $1.01M | Sell |
39,043
-26,328
| -40% | -$716K | ﹤0.01% | 538 |
|
|
2021
Q1 | $1.67M | Buy |
65,371
+5,972
| +10% | +$153K | ﹤0.01% | 510 |
|
|
2020
Q4 | $1.19M | Buy |
+59,399
| New | +$1.16M | ﹤0.01% | 516 |
|
|
2015
Q2 | – | Sell |
-106,220
| Closed | -$4.19M | – | 739 |
|
|
2015
Q1 | $4.19M | Sell |
106,220
-38,570
| -27% | -$1.42M | 0.01% | 535 |
|
|
2014
Q4 | $5.22M | Sell |
144,790
-84,780
| -37% | -$2.85M | 0.01% | 516 |
|
|
2014
Q3 | $6.78M | Sell |
229,570
-1,120
| -0.5% | -$30.9K | 0.01% | 459 |
|
|
2014
Q2 | $5.8M | Sell |
230,690
-45,340
| -16% | -$1.12M | 0.01% | 491 |
|
|
2014
Q1 | $7.12M | Sell |
276,030
-41,410
| -13% | -$1.04M | 0.01% | 459 |
|
|
2013
Q4 | $7.14M | Sell |
317,440
-151,090
| -32% | -$2.92M | 0.01% | 448 |
|
|
2013
Q3 | $6.64M | Buy |
468,530
+436,530
| +1,364% | +$5.84M | 0.02% | 431 |
|
|
2013
Q2 | $437K | Buy |
+32,000
| New | +$436K | ﹤0.01% | 663 |
|
Other funds holding NTUS
Boston Partners's NTUS Position: Q3 2022 in Review
Boston Partners sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 27,572 shares — an estimated $904K sold.
Boston Partners first reported a position in NTUS in Q2 2013 and held it in 15 quarters. The position peaked at $7.14M in Q4 2013. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.
- Boston Partners reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
- Boston Partners sold 27,572 Natus Medical Inc shares in Q3 2022, an estimated $904K.
- Boston Partners first reported a position in Natus Medical Inc in Q2 2013 and held it in 15 quarters.
- Boston Partners's Natus Medical Inc position peaked at $7.14M in Q4 2013.
- 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.
Based on Boston Partners's 13F filing for Q3 2022, filed 9 Nov 2022.